CVS Health Corporation (LON:0HRS)
London · Delayed Price · Currency is GBP · Price in USD 74.72
+0.54 (0.72%)
At close: Jan 30, 2026
CVS Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 391,690 | 370,656 | 356,623 | 321,629 | 290,912 | 267,908 | |
Revenue Growth (YoY) | 6.66% | 3.94% | 10.88% | 10.56% | 8.59% | 4.75% |
Cost of Revenue | 339,390 | 321,408 | 303,345 | 267,965 | 239,991 | 219,660 |
Gross Profit | 52,300 | 49,248 | 53,278 | 53,664 | 50,921 | 48,248 |
Selling, General & Admin | 42,153 | 41,229 | 39,205 | 37,922 | 36,764 | 34,585 |
Operating Expenses | 42,153 | 41,229 | 39,205 | 37,922 | 36,764 | 34,585 |
Operating Income | 10,147 | 8,019 | 14,073 | 15,742 | 14,157 | 13,663 |
Interest Expense | -3,090 | -2,958 | -2,658 | -2,287 | -2,503 | -2,907 |
Interest & Investment Income | 2,394 | 2,153 | 1,153 | 838 | 1,199 | 798 |
Other Non Operating Income (Expenses) | 4 | -5 | -6 | -4 | -4 | -12 |
EBT Excluding Unusual Items | 9,455 | 7,209 | 12,562 | 14,289 | 12,849 | 11,542 |
Merger & Restructuring Charges | -256 | -1,452 | -1,040 | -117 | -1,490 | -332 |
Impairment of Goodwill | -5,725 | - | - | - | -431 | - |
Gain (Loss) on Sale of Assets | 483 | - | -349 | -2,533 | - | - |
Legal Settlements | -1,540 | -100 | - | -5,803 | - | - |
Other Unusual Items | 491 | 491 | - | - | -391 | -1,440 |
Pretax Income | 2,908 | 6,148 | 11,173 | 5,836 | 10,537 | 9,770 |
Income Tax Expense | 2,480 | 1,562 | 2,805 | 1,509 | 2,548 | 2,569 |
Earnings From Continuing Operations | 428 | 4,586 | 8,368 | 4,327 | 7,989 | 7,201 |
Earnings From Discontinued Operations | - | - | - | - | - | -9 |
Net Income to Company | 428 | 4,586 | 8,368 | 4,327 | 7,989 | 7,192 |
Minority Interest in Earnings | 41 | 28 | -24 | -16 | 12 | -13 |
Net Income | 469 | 4,614 | 8,344 | 4,311 | 8,001 | 7,179 |
Net Income to Common | 469 | 4,614 | 8,344 | 4,311 | 8,001 | 7,179 |
Net Income Growth | -90.65% | -44.70% | 93.55% | -46.12% | 11.45% | 8.21% |
Shares Outstanding (Basic) | 1,265 | 1,259 | 1,285 | 1,312 | 1,319 | 1,309 |
Shares Outstanding (Diluted) | 1,265 | 1,262 | 1,290 | 1,323 | 1,329 | 1,314 |
Shares Change (YoY) | -0.37% | -2.17% | -2.49% | -0.45% | 1.14% | 0.69% |
EPS (Basic) | 0.37 | 3.66 | 6.49 | 3.29 | 6.07 | 5.48 |
EPS (Diluted) | 0.37 | 3.66 | 6.47 | 3.26 | 6.02 | 5.46 |
EPS Growth | -90.63% | -43.43% | 98.47% | -45.85% | 10.19% | 7.54% |
Free Cash Flow | 6,293 | 6,326 | 10,395 | 13,450 | 15,745 | 13,428 |
Free Cash Flow Per Share | 4.97 | 5.01 | 8.06 | 10.17 | 11.85 | 10.22 |
Dividend Per Share | 2.660 | 2.660 | 2.420 | 2.200 | 2.000 | 2.000 |
Dividend Growth | 2.31% | 9.92% | 10.00% | 10.00% | - | - |
Gross Margin | 13.35% | 13.29% | 14.94% | 16.68% | 17.50% | 18.01% |
Operating Margin | 2.59% | 2.16% | 3.95% | 4.89% | 4.87% | 5.10% |
Profit Margin | 0.12% | 1.24% | 2.34% | 1.34% | 2.75% | 2.68% |
Free Cash Flow Margin | 1.61% | 1.71% | 2.92% | 4.18% | 5.41% | 5.01% |
EBITDA | 14,753 | 12,616 | 18,439 | 19,966 | 18,643 | 18,104 |
EBITDA Margin | 3.77% | 3.40% | 5.17% | 6.21% | 6.41% | 6.76% |
D&A For EBITDA | 4,606 | 4,597 | 4,366 | 4,224 | 4,486 | 4,441 |
EBIT | 10,147 | 8,019 | 14,073 | 15,742 | 14,157 | 13,663 |
EBIT Margin | 2.59% | 2.16% | 3.95% | 4.89% | 4.87% | 5.10% |
Effective Tax Rate | 85.28% | 25.41% | 25.11% | 25.86% | 24.18% | 26.30% |
Revenue as Reported | 394,084 | 372,809 | 357,776 | 322,467 | 292,111 | 268,706 |
Advertising Expenses | - | 989 | 985 | 745 | 707 | 613 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.